Sign Up Today and Learn More About NUCLIDIUM Stock
Invest in or calculate the value of your shares in NUCLIDIUM or other pre-IPO companies through EquityZen's platform.
NUCLIDIUM Stock
NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics.
About NUCLIDIUM Stock
Founded
2018
Industries
Health Care
NUCLIDIUM Press Mentions
Stay in the know about the latest news on NUCLIDIUM
Female funding recap: List of Europe and UK startups that raised €132M funding last week
techfundingnews • Jul 15, 2025
VIVES Partners contributes to €84m funding for radiopharma company, Nuclidium
pharmafile • Jul 15, 2025
In other news this week: NUCLIDIUM raises €84M, CarOnSale drives away with €70M, EvlaBio lands €21M and more
siliconcanals • Jul 13, 2025
Nuclidium’s radiopharma approach draws $99M in series B
bioworld • Jul 13, 2025
Hefty Nuclidium fundraiser latest evidence of radiopharma boom
thepharmaletter • Jul 12, 2025
NUCLIDIUM Management
Leadership team at NUCLIDIUM
CEO and Founder
Leila Jaafar-Thiel
CFO
Claudia Halasz
Join now and verify your accreditation status to gain access to:
- NUCLIDIUM Current Valuation
- NUCLIDIUM Stock Price
- NUCLIDIUM Management
- Available deals in NUCLIDIUM and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- NUCLIDIUM Cap Table and Funding History by Share Class and Liquidity Preferences
- NUCLIDIUM Revenue and Financials
- NUCLIDIUM Highlights
- NUCLIDIUM Business Model
- NUCLIDIUM Risk Factors
- NUCLIDIUM Research Report from SACRA Research
Trading NUCLIDIUM Stock
How to invest in NUCLIDIUM stock?
Accredited investors can buy pre-IPO stock in companies like NUCLIDIUM through EquityZen funds. These investments are made available by existing NUCLIDIUM shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell NUCLIDIUM stock?
Shareholders can sell their NUCLIDIUM stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."